#ASRS2018 - Twitter Hashtag

almost 8 years ago

#usceye's Dr. Amir Kashani being interviewed at #ASRS2018, highlighting @uscibt's findings that the dry #AMD #stemcell-based implant is feasible and well tolerated. https://t.co/KhjfBSKq5F

USCEye's tweet photo. #usceye's Dr. Amir Kashani being interviewed at #ASRS2018, highlighting @uscibt's findings that the dry #AMD #stemcell-based implant is feasible and well tolerated.

https://t.co/KhjfBSKq5F https://t.co/udh6EMi7gu

0

6

0

Retinal Physician @RetinalPhys

almost 8 years ago

At #ASRS2018, Aura Biosciences presented encouraging interim data from its phase 1b/2 study of its lead program, light-activated AU-011 for the treatment of primary choroidal melanoma. https://t.co/3jDgPHS0Vv

RetinalPhys's tweet photo. At #ASRS2018, Aura Biosciences presented encouraging interim data from its phase 1b/2 study of its lead program, light-activated AU-011 for the treatment of primary choroidal melanoma. https://t.co/3jDgPHS0Vv https://t.co/ZGkLArwBgz

0

1

2

0

Kevin Kunzmann @NotADoctorKevin

almost 8 years ago

#GeneTherapy in ophthalmology was a big topic at #ASRS2018, and apparently will be a part of #AAO2018 in Chicago this year.

HCPLive @HCPLiveNews

almost 8 years ago

Multiple #AMD patients administered gene therapy RGX-314 have since stopped all #AntiVEGF treatment, according to new #phase1 results: https://t.co/IgP80vIj8d

0

2

0

Apellis Pharma @ApellisPharma

about 8 years ago

If you didn't catch Dr. Steinle's presentation at #ASRS2018 of our FILLY results in patients with #GeographicAtrophy, be sure to read @OphthTimes thorough recap here: https://t.co/L9L8gHoYG4 #Ophthalmology

0

3

0

Medscape

@Medscape

about 8 years ago

Experimental stem cell therapies for eye conditions are barely regulated and sometimes harmful. https://t.co/vjWXxEsaH9 #ASRS2018

0

4

3

0

Medscape

@Medscape

about 8 years ago

LADDER Study results: Implant may transform #MacularDegeneration treatment. https://t.co/N9PWbnPRHH #ASRS2018

0

3

2

0

IRIS @IRIStelemed

about 8 years ago

In a study led and presented by Dr. Jose Agustin Martinez, new data shows that diabetic retinopathy (DR) screening via telemedicine can have long-term benefits for patients in underserved, urban areas. #asrs2018 #telemedicine #endpreventableblindness https://t.co/0RstQX4B2w

IRIStelemed's tweet photo. In a study led and presented by Dr. Jose Agustin Martinez, new data shows that diabetic retinopathy (DR) screening via telemedicine can have long-term benefits for patients in underserved, urban areas.

#asrs2018 #telemedicine #endpreventableblindness

https://t.co/0RstQX4B2w https://t.co/SZyouu3J8l

0

3

1

0

Biosimilars Forum @USBiosimilars

about 8 years ago

New study from American Society of Retina Specialists @asrsdocs shows #biosimilars can provide safe and effective treatment for patients treating retinal diseases. Learn more https://t.co/aXw3kFmffT #ASRS2018

0

2

0

Medscape

@Medscape

about 8 years ago

Spikes in #aflibercept inflammations worry specialists. https://t.co/sBaDlQvJpF #ASRS2018

0

3

0

HCPLive @HCPLiveNews

about 8 years ago

From #ASRS2018: How soon will US #retina disease patients have access to brolucizumab and gene therapies: https://t.co/rUOlkwFdtZ

0

1

2

0

Medscape

@Medscape

about 8 years ago

OCT angiography predicts exudation in macular degeneration. https://t.co/VWiAKHw8KV #ASRS2018

0

2

0

Roche @Roche

about 8 years ago

We’re initiating our phase III #ophthalmology programme with three global studies in #retinal #diseases in 2018. https://t.co/Fy4avnebr0 #EyeCare #ASRS2018

Roche's tweet photo. We’re initiating our phase III #ophthalmology programme with three global studies in #retinal #diseases in 2018. https://t.co/Fy4avnebr0 #EyeCare #ASRS2018 https://t.co/NX90eCa6BZ

1

6

1

0

Roche @Roche

about 8 years ago

Positive phase II results for the first-ever eye implant to demonstrate sustained delivery of treatment for neovascular age-related #MacularDegeneration, designed to reduce the burden of frequent treatment injections. https://t.co/CmYYo5F4D1 #ASRS2018

Roche's tweet photo. Positive phase II results for the first-ever eye implant to demonstrate sustained delivery of treatment for neovascular age-related #MacularDegeneration, designed to reduce the burden of frequent treatment injections. https://t.co/CmYYo5F4D1 #ASRS2018 https://t.co/0t4YdoU145

0

2

0

Roche @Roche

about 8 years ago

We’re pleased to announce new positive phase II #ophthalmology data in #retinal #disease, presented at #ASRS2018. https://t.co/NsyoGyVm13 $RHHBY $ROG #EyeCare

Roche's tweet photo. We’re pleased to announce new positive phase II #ophthalmology data in #retinal #disease, presented at #ASRS2018. https://t.co/NsyoGyVm13 $RHHBY $ROG #EyeCare https://t.co/WHoHK3Ez2Z

0

4

0

Ophthalmology Times @OphthTimes

about 8 years ago

Brolucizumab: Next-generation of anti-VEGF therapy? https://t.co/pn36XXmLtM #ASRS2018

0

7

5

1

0

Genentech @genentech

about 8 years ago

We had a great time at #ASRS2018. We’ll see everyone again at #AAO2018 in October! https://t.co/Itmbhl5i7C

0

3

0

Clearside Biomedical, Inc. @clearsidebio

about 8 years ago

Today, results from the pivotal Phase 3 PEACHTREE study in non-infectious uveitis were presented at #ASRS2018 @clearsidebio

0

1

0

Vancouver CVB @MeetVancouver

about 8 years ago

We'd like to thank @asrsdocs #ASRS2018 attendees for visiting Vancouver for their Annual Meeting. We hope you enjoyed your stay!

MeetVancouver's tweet photo. We'd like to thank @asrsdocs #ASRS2018 attendees for visiting Vancouver for their Annual Meeting. We hope you enjoyed your stay! https://t.co/E0bVSX1Tdr

0

1

0

HCPLive @HCPLiveNews

about 8 years ago

Results of the #ASRS2018 annual Preferences and Trends Survey have been presented. What does the average #retina specialist look like, and practice, in 2018? https://t.co/HE3H0MZMux

1

2

1

0

ASRS

@asrsdocs

about 8 years ago

Which is better: pneumatic retinopexy or vitrectomy for primary retinal detachment? Recent trial data may make your decision PIVOT! Retinal Detachment Symposium starts at 8 am. #ASRS2018

0

2

0

Top Tweets for #ASRS2018

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users